Differentiation of diabetes by pathophysiology, natural history, and prognosis

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023 · see citing works

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315 · see citing works

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782 · see citing works

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247 · see citing works

10-year follow-up of intensive glucose control in type 2 diabetes

Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · see citing works

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · see citing works

The metabolic syndrome

Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,283 · see citing works

The metabolic syndrome

Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,566 · see citing works

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487 · see citing works

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

(1998) · PubMed · Cited by 4,290 · see citing works

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129 · see citing works

Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children

Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,019 · see citing works

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · see citing works

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · see citing works

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · see citing works

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614 · see citing works

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Green, J. B., Bethel, M. A., Armstrong, P. W., Buse, J. B., Engel, S. S., Garg, J., Josse, R., Kaufman, K. D., Koglin, J., Korn, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501352 · Cited by 2,577 · see citing works

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502 · see citing works

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479 · see citing works

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509225 · Cited by 2,409 · see citing works

Weight gain as a risk factor for clinical diabetes mellitus in women

Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064 · see citing works

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segrè, A. V., Steinthorsdottir, V., Strawbridge, R. J., Khan, H., Grallert, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2383 · Cited by 1,912 · see citing works

Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men

Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808 · see citing works

Changes in diabetes-related complications in the United States, 1990-2010

Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749 · see citing works

Continuous glucose monitoring and intensive treatment of type 1 diabetes

(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559 · see citing works

Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009

Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412 · see citing works

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children

Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312 · see citing works

The Metabolic Syndrome

Grundy, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,225 · see citing works

Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216 · see citing works

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · see citing works

Diabetic kidney disease: a report from an ADA Consensus Conference

Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153 · see citing works

Five stages of evolving beta-cell dysfunction during progression to diabetes

Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126 · see citing works

Epidemiology of type 1 diabetes

Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092 · see citing works

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

Karvonen, M., Viik-Kajander, M., Moltchanova, E., Libman, I., LaPorte, R., & Tuomilehto, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1516 · Cited by 1,072 · see citing works

Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis

Agardh, E. E., Alle­beck, P., Hallqvist, J., Moradi, T., & Sidorchuk, A. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr029 · Cited by 1,067 · see citing works

Diabetes in identical twins

Barnett, A. H., Eff, C., Leslie, R. D., & Pyke, D. A. (1981) · Diabetologia · doi:10.1007/bf00262007 · Cited by 966 · see citing works

The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes

Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945 · see citing works

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein‐Fuchs, J., Hirsch, I. B., Kalantar‐Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 907 · see citing works

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways

Scott, R. A., Lagou, V., Welch, R., Wheeler, E., Montasser, M. E., Luan, J., Mägi, R., Strawbridge, R. J., Rehnberg, E., Gustafsson, S., et al. (2012) · Nature Genetics · doi:10.1038/ng.2385 · Cited by 817 · see citing works

Toward defining the autoimmune microbiome for type 1 diabetes

Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.92 · Cited by 806 · see citing works

The changing natural history of nephropathy in type I Diabetes

Królewski, A. S., Warram, J. H., Christlieb, A. R., Busick, E. J., & Kahn, C. R. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90284-0 · Cited by 778 · see citing works

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention study: A 23-year follow-up study

Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684 · see citing works

Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010

Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., et al. (2015) · JAMA · doi:10.1001/jama.2014.16425 · Cited by 621 · see citing works

Clinical Inertia in People With Type 2 Diabetes

Khunti, K. K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0331 · Cited by 615 · see citing works

Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease

Sharma, K., Karl, B., Mathew, A. V., Gangoiti, J. A., Wassel, C. L., Saito, R., Pu, M., Sharma, S., You, Y.-H., Wang, L., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020126 · Cited by 571 · see citing works

Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies

Ziegler, A. (2003) · JAMA · doi:10.1001/jama.290.13.1721 · Cited by 562 · see citing works

β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis

Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540 · cited 1× · see citing works

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

Perreault, L., Pan, Q., Mather, K. J., Watson, K. E., Hamman, R. F., & Kahn, S. E. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60525-x · Cited by 532 · see citing works

Timing of initial cereal exposure in infancy and risk of islet autoimmunity

Norris, J. M. (2003) · JAMA · doi:10.1001/jama.290.13.1713 · Cited by 515 · see citing works

Type 1 Diabetes Mellitus and Cardiovascular Disease

de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 504 · see citing works

Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

Murphy, R., Ellard, S., & Hattersley, A. T. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0778 · Cited by 502 · see citing works

Neuropathy and related findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study

Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2114 · Cited by 499 · see citing works

Environmental Triggers and Determinants of Type 1 Diabetes

Knip, M., Veijola, R., Virtanen, S. M., Hyöty, H., Vaarala, O., & Åkerblom, H. K. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s125 · Cited by 496 · see citing works

Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic Review and Meta-analysis

Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493 · see citing works

Loss-of-function mutations in SLC30A8 protect against type 2 diabetes

Go-T2D Consortium, Flannick, J., T2D-GENES Consortium, Thorleifsson, G., Beer, N. L., Jacobs, S. B. R., Grarup, N., Burtt, N. P., Mahajan, A., Fuchsberger, C., et al. (2014) · Nature Genetics · doi:10.1038/ng.2915 · Cited by 492 · see citing works

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483 · see citing works

Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin

Wilding, J. P. H., Woo, V., Soler, N. G., Pahor, A., Sugg, J., Rohwedder, K., Parikh, S., & for the Dapagliflozin 006 Study Group* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-6-201203200-00003 · Cited by 469 · see citing works

Genetics of Type 2 Diabetes—Pitfalls and Possibilities

Prasad, R., & Groop, L. (2015) · Genes · doi:10.3390/genes6010087 · Cited by 458 · see citing works

The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study

the TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444 · see citing works

Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association

de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 434 · see citing works

Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk

Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R. (2014) · Diabetes · doi:10.2337/db13-0468 · Cited by 403 · see citing works

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

Gaulton, K. J., Ferreira, T. C., Lee, Y., Raimondo, A., Mägi, R., Reschen, M. E., Mahajan, A., Locke, A. E., Rayner, N. W., Robertson, N., et al. (2015) · Nature Genetics · doi:10.1038/ng.3437 · Cited by 390 · see citing works

Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects

Groop, L., Forsblom, C. M., Lehtovirta, M., Tuomi, T., Karanko, S., Nissén, M., Ehrnstrom, B. O., Forsén, B., Isomaa, B., Snickars, B., et al. (1996) · Diabetes · doi:10.2337/diab.45.11.1585 · Cited by 384 · see citing works

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes

Campbell‐Thompson, M., Fu, A. D., Kaddis, J. S., Wasserfall, C. H., Schatz, D., Pugliese, A., & Atkinson, M. A. (2015) · Diabetes · doi:10.2337/db15-0779 · Cited by 358 · see citing works

Concordance for islet autoimmunity among monozygotic twins

Redondo, M. J., Jeffrey, J., Fain, P. R., Eisenbarth, G. S., & Orban, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805398 · Cited by 353 · see citing works

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

Oram, R. A., Patel, K. A., Hill, A., Shields, B. M., McDonald, T. J., Jones, A. G., Hattersley, A. T., & Weedon, M. N. (2015) · Diabetes Care · doi:10.2337/dc15-1111 · Cited by 351 · see citing works

Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus

Henry, R. R., Wallace, P., & Olefsky, J. M. (1986) · Diabetes · doi:10.2337/diab.35.9.990 · Cited by 325 · cited 1× · see citing works

Fall in C-Peptide During First 2 Years From Diagnosis

Greenbaum, C. J., Beam, C. A., Boulware, D., Gitelman, S. E., Gottlieb, P. A., Herold, K. C., Lachin, J. M., McGee, P., Palmer, J. P., Pescovitz, M. D., et al. (2012) · Diabetes · doi:10.2337/db11-1538 · Cited by 319 · see citing works

The importance of weight management in type 2 diabetes mellitus

Wilding, J. P. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12384 · Cited by 314 · see citing works

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., Weyer, C., & Kolterman, O. G. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01319.x · Cited by 307 · see citing works

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

Oram, R. A., Jones, A. G., Besser, R. E. J., Knight, B. A., Shields, B. M., Brown, R. J., Hattersley, A. T., & McDonald, T. J. (2014) · Diabetologia · doi:10.1007/s00125-013-3067-x · Cited by 298 · see citing works

Mapping Genes in Diabetes: Genetic Epidemiological Perspective

Rich, S. S. (1990) · Diabetes · doi:10.2337/diab.39.11.1315 · Cited by 288 · see citing works

Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects

Long, S. A., Cerosaletti, K. M., Bollyky, P. L., Tatum, M., Shilling, H. G., Zhang, S., Zhang, Z., Pihoker, C., Sanda, S., Greenbaum, C. J., et al. (2009) · Diabetes · doi:10.2337/db09-0694 · Cited by 284 · see citing works

Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study

Dujić, T., Zhou, K., Donnelly, L. A., Tavendale, R., Palmer, C. N. A., & Pearson, E. R. (2014) · Diabetes · doi:10.2337/db14-1388 · Cited by 283 · see citing works

Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk

Hu, X.-L., Deutsch, A., Lenz, T., Onengut-Gumuscu, S., Han, B., Chen, W.-M., Howson, J., Todd, J., de Bakker, P., Rich, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3353 · Cited by 272 · see citing works

Incidence of End-stage Renal Disease in Patients With Type 1 Diabetes

Finne, P. (2005) · JAMA · doi:10.1001/jama.294.14.1782 · Cited by 271 · see citing works

Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes

the BABYDIAB-BABYDIET Study Group, Ziegler, A.-G., & Bonifacio, E. (2012) · Diabetologia · doi:10.1007/s00125-012-2472-x · Cited by 264 · see citing works

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1

Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0934 · Cited by 260 · see citing works

Extreme genetic risk for type 1A diabetes

Aly, T. A., Ide, A., Jahromi, M. M., Barker, J. M., Fernando, M. S., Babu, S. R., Yu, L., Miao, D., Erlich, H. A., Fain, P. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606349103 · Cited by 256 · see citing works

HLA Class I and Genetic Susceptibility to Type 1 Diabetes

Noble, J. A., Valdes, A. M., Varney, M. D., Carlson, J. A., Moonsamy, P., Fear, A. L., Lane, J. A., Lavant, E., Rappner, R., Louey, A., et al. (2010) · Diabetes · doi:10.2337/db10-0699 · Cited by 254 · see citing works

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

Gong, Q., Gregg, E. W., Wang, J., An, Y., Zhang, P., Yang, W., Li, H., Li, H., Jiang, Y., Shuai, Y., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1948-9 · Cited by 251 · see citing works

Relationship between β‐cell mass and diabetes onset

Matveyenko, A. V., & Butler, P. C. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00939.x · Cited by 249 · see citing works

A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes

Wadén, J., Forsblom, C. M., Thorn, L. M., Gordin, D., Saraheimo, M., Groop, P., & on behalf of the Finnish Diabetic Nephropathy Study Group (2009) · Diabetes · doi:10.2337/db09-0693 · Cited by 238 · see citing works

Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk

Parikka, V., Näntö-Salonen, K., Saarinen, M., Simell, T., Ilonen, J., Hyöty, H., Veijola, R., Knip, M., & Simell, O. (2012) · Diabetologia · doi:10.1007/s00125-012-2523-3 · Cited by 235 · see citing works

7. Approaches to Glycemic Treatment

American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s010 · Cited by 225 · see citing works

Islet-Cell Antibodies and Beta-Cell Function in Monozygotic Triplets and Twins Initially Discordant for Type I Diabetes Mellitus

Srikanta, S., Ganda, O. P., Eisenbarth, G. S., & Soeldner, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302103080607 · Cited by 224 · see citing works

First-Degree Relatives of Patients with Type I Diabetes Mellitus

Srikanta, S., Ganda, O. P., Rabizadeh, A., Soeldner, J. S., & Eisenbarth, G. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508223130801 · Cited by 221 · see citing works

Latent Autoimmune Diabetes in Adults

Stenström, G., Gottsäter, A., Bakhtadze, E., Berger, B., & Sundkvist, G. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s68 · Cited by 213 · see citing works

Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment

Leslie, R. D., Palmer, J. P., Schloot, N. C., & Lernmark, Å. (2015) · Diabetologia · doi:10.1007/s00125-015-3789-z · Cited by 205 · see citing works

Increased Expression of Antioxidant and Antiapoptotic Genes in Islets That May Contribute to β-Cell Survival During Chronic Hyperglycemia

Laybutt, D. R., Kaneto, H., Hasenkamp, W. M., Grey, S. T., Jonas, J., Sgroi, D. C., Groff, A., Ferran, C. J., Bonner‐Weir, S., Sharma, A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.2.413 · Cited by 202 · see citing works

The use of metformin in type 1 diabetes: a systematic review of efficacy

Vella, S., Buetow, L., Royle, P., Livingstone, S., Colhoun, H. M., & Petrie, J. R. (2010) · Diabetologia · doi:10.1007/s00125-009-1636-9 · Cited by 201 · see citing works

Ectopic Fat Storage in the Pancreas, Liver, and Abdominal Fat Depots: Impact on β-Cell Function in Individuals with Impaired Glucose Metabolism

van der Zijl, N. J., Goossens, G. H., Moors, C. C. M., van Raalte, D. H., Muskiet, M. H. A., Pouwels, P. J. W., Blaak, E. E., & Diamant, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1722 · Cited by 199 · see citing works

Determinants of diabetes remission and glycemic control after bariatric surgery

Panunzi, S., Carlsson, L., De Gaetano, A., Peltonen, M., Rice, T., Sjöström, L., Mingrone, G., & Dixon, J. B. (2016) · Diabetes Care · doi:10.2337/dc15-0575 · Cited by 198 · see citing works

Predicting Type 1 Diabetes Using Biomarkers

Bonifacio, E. E. (2015) · Diabetes Care · doi:10.2337/dc15-0101 · Cited by 191 · see citing works

The Early Natural History of Nephropathy in Type 1 Diabetes

Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., & for the International Diabetic Nephropathy Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2164 · Cited by 190 · see citing works

Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: the environmental determinants of diabetes in the young (TEDDY)

Steck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2426 · Cited by 185 · see citing works

Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga

Bakris, G. L., & Molitch, M. E. (2014) · Diabetes Care · doi:10.2337/dc13-1870 · Cited by 185 · see citing works

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

Jones, A. G., McDonald, T. J., Shields, B. M., Hill, A. V., Hyde, C., Knight, B., & Hattersley, A. T. (2015) · Diabetes Care · doi:10.2337/dc15-0258 · Cited by 181 · see citing works

Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus

Yoshioka, N., Kuzuya, T., Matsuda, A., Taniguchi, M., & Iwamoto, Y. (1988) · Diabetologia · doi:10.1007/bf02341503 · Cited by 175 · see citing works

A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes

Edelman, S., Garg, S., Frias, J., Maggs, D., Wang, Y., Zhang, B., Strobel, S., Lutz, K., & Kolterman, O. (2006) · Diabetes Care · doi:10.2337/dc06-0042 · Cited by 166 · see citing works

Familial Risks for Type 2 Diabetes in Sweden

Hemminki, K., Li, X., Sundquist, K., & Sundquist, J. (2009) · Diabetes Care · doi:10.2337/dc09-0947 · Cited by 165 · see citing works

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Kielgast, U. L., Krarup, T., Holst, J. J., & Madsbad, S. (2011) · Diabetes Care · doi:10.2337/dc11-0096 · Cited by 165 · see citing works

Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study

Törn, C., Hadley, D., Lee, H. S., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A. G., Schatz, D., Akolkar, B., et al. (2014) · Diabetes · doi:10.2337/db14-1497 · Cited by 150 · see citing works

Optimum BMI Cut Points to Screen Asian Americans for Type 2 Diabetes

Araneta, M. R. G., Kanaya, A. M., Hsu, W. C., Chang, H. K., Grandinetti, A., Boyko, E. J., Hayashi, T., Kahn, S. E., Leonetti, D. L., McNeely, M. J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2071 · Cited by 148 · see citing works

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance

Dietel, M., Jöhrens, K., von Laffert, M., Hummel, M., Bläker, H., Pfitzner, B. M., Lehmann, A., Denkert, C., Darb‐Esfahani, S., Lenze, D., et al. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.39 · Cited by 146 · see citing works

An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells

Long, S., Cerosaletti, K. M., Wan, J. Y., Ho, J.-C., Tatum, M., Wei, S., Shilling, H. G., & Buckner, J. H. (2010) · Genes and Immunity · doi:10.1038/gene.2010.54 · Cited by 143 · see citing works

Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β ‐cell apoptosis

Santín, I., & Eizirik, D. L. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12162 · Cited by 140 · see citing works

Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset

Ferrannini, E., Mari, A., Nofrate, V., Sosenko, J. M., Skyler, J. S., & for the DPT-1 Study Group (2010) · Diabetes · doi:10.2337/db09-1378 · Cited by 140 · see citing works

Genetic and Epigenetic Factors in Etiology of Diabetes Mellitus Type 1

Stankov, K., Benc, D., & Drašković, D. (2013) · PEDIATRICS · doi:10.1542/peds.2013-1652 · Cited by 135 · see citing works

Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic Control

Nichols, G. A., Koo, Y. H., & Shah, S. N. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0139-y · Cited by 134 · see citing works

No Deterioration in Glycemic Control in HNF-1α Maturity-Onset Diabetes of the Young Following Transfer From Long-Term Insulin to Sulphonylureas

Shepherd, M. H., Pearson, E. R., Houghton, J., Salt, G., Ellard, S., & Hattersley, A. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3191-a · Cited by 129 · see citing works

Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

Basu, A., Dalla Man, C., Basu, R., Toffolo, G., Cobelli, C., & Rizza, R. A. (2009) · Diabetes Care · doi:10.2337/dc08-1826 · Cited by 129 · see citing works

Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass

Portha, B., Chavey, A., & Movassat, J. (2011) · Experimental Diabetes Research · doi:10.1155/2011/105076 · Cited by 127 · see citing works

TEDDY–The Environmental Determinants of Diabetes in the Young: An Observational Clinical Trial

HAGOPIAN, W. A., LERNMARK, Å., REWERS, M. J., SIMELL, O. G., SHE, J., ZIEGLER, A. G., KRISCHER, J. P., & AKOLKAR, B. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1375.049 · Cited by 125 · see citing works

Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients

Vardi, P., Crisa, L., Jackson, R. A., Dumont Herskowitz, R., Wolfsdorf, J. I., Einhorn, D., Linarelli, L., Dolinar, R., Wentworth, S., Brink, S. J., et al. (1991) · Diabetologia · doi:10.1007/bf00500379 · Cited by 122 · see citing works

TYK2 , a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells

Marroquí, L., dos Santos, R. S., Fløyel, T., Grieco, F. A., Santín, I., Beeck, A. O. D., Marselli, L., Marchetti, P., Pociot, F., & Eizirik, D. L. (2015) · Diabetes · doi:10.2337/db15-0362 · Cited by 121 · see citing works

Insights Into the Molecular Mechanism for Type 2 Diabetes Susceptibility at the <i>KCNQ1</i> Locus From Temporal Changes in Imprinting Status in Human Islets

Travers, M. E., Mackay, D. J. G., Dekker Nitert, M., Morris, A. P., Lindgren, C. M., Berry, A., Johnson, P. R., Hanley, N., Groop, L. C., McCarthy, M. I., et al. (2013) · Diabetes · doi:10.2337/db12-0819 · Cited by 118 · see citing works

Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes

Weyer, C., Gottlieb, A., Kim, D. D. H., Lutz, K., Schwartz, S. L., Gutiérrez, M. E. H., Wang, Y., Ruggles, J. A., Kolterman, O., & Maggs, D. G. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3074 · Cited by 107 · see citing works

Diabetic Ketoacidosis With Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes

Peters, A. L., Henry, R. R., Thakkar, P., Tong, C., & Alba, M. (2016) · Diabetes Care · doi:10.2337/dc15-1995 · Cited by 106 · see citing works

We Can Change the Natural History of Type 2 Diabetes

Phillips, L. S., Ratner, R. E., Buse, J. B., & Kahn, S. E. (2014) · Diabetes Care · doi:10.2337/dc14-0817 · Cited by 105 · see citing works

A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial–Type 1

Sosenko, J. M., Krischer, J. P., Palmer, J. P., Mahon, J. L., Cowie, C. C., Greenbaum, C. J., Cuthbertson, D. D., Lachin, J. M., Skyler, J. S., & the Diabetes Prevention Trial–Type 1 Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1459 · Cited by 105 · see citing works

MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA

Colli, M. L., Moore, F., Gurzov, E. N., Ortis, F., & Eizirik, D. L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp474 · Cited by 103 · see citing works

Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study

Vehik, K., Lynch, K. F., Schatz, D. A., Akolkar, B., Hagopian, W., Rewers, M., She, J.-X., Simell, O., Toppari, J., Ziegler, A.-G., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0181 · Cited by 103 · see citing works

It's Time to Overcome Clinical Inertia

Phillips, L. S., & Twombly, J. G. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00011 · Cited by 102 · see citing works

Type I (insulin dependent) diabetes: a disease of slow clinical onset?

Tarn, A. C., Smith, C. P., Spencer, K. M., Bottazzo, G. F., & Gale, E. (1987) · BMJ · doi:10.1136/bmj.294.6568.342 · Cited by 101 · see citing works

Addition of rosiglitazone to metformin is most effective in obese, insulin‐resistant patients with type 2 diabetes

Jones, T., Sautter, M. C., Gaal, L. F. V., & Jones, N. P. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00258.x · Cited by 100 · see citing works

Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial

Garg, S. K., Moser, E. G., Bode, B. W., Klaff, L. J., Hiatt, W. R., Beatson, C. R., & Snell‐Bergeon, J. K. (2012) · Endocrine Practice · doi:10.4158/ep12100.or · Cited by 98 · see citing works

Personalized medicine in diabetes: the role of ‘omics’ and biomarkers

Pearson, E. R. (2016) · Diabetic Medicine · doi:10.1111/dme.13075 · Cited by 94 · see citing works

Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments

Raju, B., Arbelaez, A. M., Breckenridge, S. M., & Cryer, P. E. (2006) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2005-2798 · Cited by 93 · see citing works

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

Sosenko, J. M., Skyler, J. S., Beam, C. A., Krischer, J. P., Greenbaum, C. J., Mahon, J., Rafkin, L. E., Matheson, D., Herold, K. C., Palmer, J. P., et al. (2013) · Diabetes · doi:10.2337/db13-0656 · Cited by 85 · see citing works

Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody

Colman, P. G., Steele, C. E., Couper, J., Beresford, S., Powell, T., Kewming, K., Pollard, A. C., Gellert, S. A., Tait, B. D., Honeyman, M. C., et al. (2000) · Diabetologia · doi:10.1007/s001250050030 · Cited by 83 · see citing works

Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors

Ohki, T., Isogawa, A., Toda, N., & Tagawa, K. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0383-1 · Cited by 79 · see citing works

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

Sosenko, J. M., Palmer, J. P., Rafkin‐Mervis, L., Krischer, J. P., Cuthbertson, D. D., Matheson, D., & Skyler, J. S. (2008) · Diabetes Care · doi:10.2337/dc08-0935 · Cited by 78 · see citing works

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

Sosenko, J. M., Palmer, J. P., Rafkin-Mervis, L., Krischer, J. P., Cuthbertson, D., Mahon, J., Greenbaum, C. J., Cowie, C. C., Skyler, J. S., & the Diabetes Prevention Trial–Type 1 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2140 · Cited by 76 · see citing works

Relative contributions of β-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia

van Haeften, T. W., Pimenta, W. P., Mitrakou, A., Korytkowski, M., Jenssen, T. G., Yki‐Järvinen, H., & Gerich, J. E. (2000) · Metabolism · doi:10.1053/meta.2000.9526 · Cited by 71 · see citing works

Rosiglitazone preserves islet β-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study

Yang, Z., Zhou, Z., Li, X., Huang, G., & Lin, J. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.044 · Cited by 65 · see citing works

The Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes

Strowig, S. M., & Raskin, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1562 · Cited by 64 · see citing works

Identification of Tyrosine Phosphatase 2(256–760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients

Tiberti, C., Giordano, C. S. D. S., Locatelli, M., Bosi, E., Bottazzo, G. F., Buzzetti, R., Cucinotta, D., Galluzzo, A., Falorni, A., & Dotta, F. (2008) · Diabetes · doi:10.2337/db07-0874 · Cited by 63 · see citing works

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

Sosenko, J. M., Palmer, J. P., Rafkin, L. E., Krischer, J. P., Cuthbertson, D., Greenbaum, C. J., Eisenbarth, G., Skyler, J. S., & Diabetes Prevention Trial–Type 1 Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1770 · Cited by 62 · see citing works

Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study

Sosenko, J. M., Skyler, J. S., Mahon, J. L., Krischer, J. P., Beam, C. A., Boulware, D. C., Greenbaum, C. J., Rafkin, L. E., Cowie, C. C., Cuthbertson, D. D., et al. (2011) · Diabetes Care · doi:10.2337/dc11-0641 · Cited by 61 · see citing works

Increasing the Accuracy of Oral Glucose Tolerance Testing and Extending Its Application to Individuals With Normal Glucose Tolerance for the Prediction of Type 1 Diabetes

Sosenko, J. M., Palmer, J. P., Greenbaum, C. J., Mahon, J. L., Cowie, C. C., Krischer, J. P., Chase, H. P., White, N. H., Buckingham, B. A., Herold, K. C., et al. (2006) · Diabetes Care · doi:10.2337/dc06-1615 · Cited by 60 · see citing works

Confirmation of novel type 1 diabetes risk loci in families

Cooper, J. D., Howson, J. M. M., Smyth, D. J., Walker, N. M., Stevens, H. E., Yang, J. H. M., She, J., Eisenbarth, G. S., Rewers, M., Todd, J. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2450-3 · Cited by 60 · see citing works

Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia

Holstein, A., Hahn, M., Patzer, O. M., Seeringer, A., Kovacs, P. L., & Stingl, J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0976-1 · Cited by 59 · see citing works

Type 1 diabetes: primary antigen/peptide/register/trimolecular complex

Sosinowski, T., & Eisenbarth, G. S. (2012) · Immunologic research · doi:10.1007/s12026-012-8367-6 · Cited by 59 · see citing works

Potential viral pathogenic mechanism in human type 1 diabetes

Schneider, D., & von Herrath, M. G. (2014) · Diabetologia · doi:10.1007/s00125-014-3340-7 · Cited by 57 · see citing works

Effects of Non-HLA Gene Polymorphisms on Development of Islet Autoimmunity and Type 1 Diabetes in a Population With High-Risk HLA-DR,DQ Genotypes

Steck, A. K., Wong, R., Wagner, B. D., et al. (2012) · Diabetes · doi:10.2337/db11-1228 · Cited by 57 · see citing works

Diagnosis of pre-type I diabetes

Chase, H. P., Voss, M. A., Butler–Simon, N., et al. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80192-0 · Cited by 54 · see citing works

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes

Mudaliar, S. R. D., Armstrong, D. A., Mavian, A. A., O'Connor‐Semmes, R. L., Mydlow, P. K., Ye, J., Hussey, E. K., Nunez, D. J., Henry, R. R., & Dobbins, R. L. (2012) · Diabetes Care · doi:10.2337/dc12-0508 · Cited by 53 · see citing works

Debate: CON Position. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial

Glassock, R. J. (2010) · American Journal of Nephrology · doi:10.1159/000313553 · Cited by 52 · see citing works

Genes Affecting β-Cell Function in Type 1 Diabetes

Fløyel, T., Kaur, S., & Pociot, F. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0655-9 · Cited by 51 · see citing works

Influence of in vivo Hemoglobin Carbamylation on HbA1c Measurements by Various Methods

Chachou, A., Randoux, C., Millart, H. G., Chanard, J., & Gillery, P. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.046 · Cited by 50 · see citing works

Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo‐controlled,double‐blind, multicentre study

Riccardi, G., Giacco, R., Parillo, M., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00047.x · Cited by 50 · see citing works

Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient

Digon, B. J., Rother, K. I., Hirshberg, B., & Harlan, D. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3191 · Cited by 47 · see citing works

Impact of Islet Autoimmunity on the Progressive β-Cell Functional Decline in Type 2 Diabetes

Brooks‐Worrell, B., Boyko, E. J., & Palmer, J. P. (2014) · Diabetes Care · doi:10.2337/dc14-0961 · Cited by 45 · see citing works

Overlap of Genetic Susceptibility to Type 1 Diabetes, Type 2 Diabetes, and Latent Autoimmune Diabetes in Adults

Basile, K. J., Guy, V. C., Schwartz, S. S., & Grant, S. F. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0550-9 · Cited by 44 · see citing works

Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?

Serhiyenko, V. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.245 · Cited by 42 · see citing works

Ten-Year Prognosis of Impaired Glucose Tolerance in Siblings of Patients with Insulin-dependent Diabetes

Rosenbloom, A. L., Hunt, S. S., Rosenbloom, E. K., & Maclaren, N. K. (1982) · Diabetes · doi:10.2337/diab.31.5.385 · Cited by 42 · see citing works

Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus.

Ginsberg‐Fellner, F., Witt, M. E., Franklin, B. H., et al. (1985) · PubMed · Cited by 41 · see citing works

Autoimmunity and familial risk of type 1 diabetes

Hämäläinen, A.-M., & Knip, M. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0025-2 · Cited by 40 · see citing works

Virus Infections and Type 1 Diabetes Risk

Roivainen, M., & Klingel, K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0139-x · Cited by 39 · see citing works

Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins

Beer, S. F., Heaton, D., Alberti, K. G. M. M., Pyke, D. A., & Leslie, R. D. G. (1990) · Diabetologia · doi:10.1007/bf00405112 · Cited by 38 · see citing works

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)

Sosenko, J. M., Skyler, J. S., Krischer, J. P., Greenbaum, C. J., Mahon, J., Rafkin, L. E., Cuthbertson, D., Cowie, C., Herold, K., Eisenbarth, G., et al. (2010) · Diabetes · doi:10.2337/db10-0534 · Cited by 38 · see citing works

TCF7L2 Polymorphism, Weight Loss and Proinsulin∶Insulin Ratio in the Diabetes Prevention Program

McCaffery, J. M., Jablonski, K. A., Franks, P. W., Dagogo-Jack, S. E., Wing, R. R., Knowler, W. C., Delahanty, L. M., Dabelea, D., Hamman, R. F., Shuldiner, A. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021518 · Cited by 35 · see citing works

Noninsulin glucose-lowering agents for the treatment of patients on dialysis

Flynn, C. A., & Bakris, G. L. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.12 · Cited by 34 · see citing works

Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes

REDONDO, M. J., Muniz, J., Rodríguez, L. M., Iyer, D., Vaziri‐Sani, F., Haymond, M. W., Hampe, C. S., Metzker, M. L., Grant, S. F. A., & Balasubramanyam, A. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2013-000008 · Cited by 34 · see citing works

Triad of Markers for Identifying Children at High Risk of Developing Insulin-Dependent Diabetes Mellitus

Ginsberg‐Fellner, F. (1985) · JAMA · doi:10.1001/jama.1985.03360110059024 · Cited by 34 · see citing works

Cardiovascular disease in patients with renal disease: the role of statins

Fellström, B., Holdaas, H., Jardine, A. G., Svensson, M. K. E., Gottlow, M., Schmieder, R. E., Zannad, F. M., & on behalf of the AURORA Study Group (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802622064 · Cited by 31 · see citing works

Clustering of Risk Factors in Parents of Patients With Type 1 Diabetes and Nephropathy

Thorn, L. M., Forsblom, C. M., Fagerudd, J. A., Pettersson-Fernholm, K., Kilpikari, R., Groop, P., & on behalf of the FinnDiane Study Group (2007) · Diabetes Care · doi:10.2337/dc06-2033 · Cited by 30 · see citing works

Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated ( ATM ), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistance

Connelly, P. J., Smith, N. F., Chadwick, R., Exley, A., Shneerson, J. M., & Pearson, E. R. (2015) · Diabetic Medicine · doi:10.1111/dme.13037 · Cited by 30 · see citing works

Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetes

Twito, O. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.345 · Cited by 27 · see citing works

Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?

Weir, M. R., & Bakris, G. L. (2010) · American Journal of Nephrology · doi:10.1159/000292500 · Cited by 26 · see citing works

Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?

Kalaitzidis, R., & Bakris, G. L. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32832edc99 · Cited by 25 · see citing works

Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches

Bergman, M., Dankner, R. S., Roth, J., & Narayan, K. M. V. (2013) · Endocrine · doi:10.1007/s12020-013-9873-6 · Cited by 22 · see citing works

Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes

Shimada, A., Shigihara, T., Okubo, Y., Katsuki, T., Yamada, Y., & Oikawa, Y. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1235 · Cited by 22 · see citing works

Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients

Brooks‐Worrell, B., & Palmer, J. P. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12012 · Cited by 20 · see citing works

GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach

Crisci, I., Aragona, M., Politi, K. S., Daniele, G., & Prato, S. D. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0800-6 · Cited by 18 · see citing works

Is Fenofibrate a Reasonable Treatment for Diabetic Microvascular Disease?

Simó, R., Simó‐Servat, O., & Hernández, C. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0599-0 · Cited by 18 · see citing works

2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2022</i>

American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792 · see citing works

2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2020</i>

American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187 · see citing works

2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2021</i>

American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116 · see citing works

2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2018</i>

American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159 · see citing works

2. Diagnosis and Classification of Diabetes: <i>Standards of Care in Diabetes—2024</i>

American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086 · see citing works

2. Classification and Diagnosis of Diabetes

American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603 · see citing works

2. Diagnosis and classification of diabetes: standards of care in diabetes-2025

American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393 · see citing works

Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis

Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., Hayes, M. G., & Dunaif, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003132 · Cited by 297 · see citing works

Genetics of type 1 diabetes

Redondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216 · see citing works

Glucose biosensors in clinical practice: principles, limits and perspectives of currently used devices

Pullano, S. A., Greco, M., Bianco, M. G., Foti, D., Brunetti, A., & Fiorillo, A. S. (2022) · Theranostics · doi:10.7150/thno.64035 · Cited by 210 · see citing works

Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance

Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199 · see citing works

Diabetes and Cancer: Risk, Challenges, Management and Outcomes

Shahid, R. K., Ahmed, S., Le, D., & Yadav, S. (2021) · Cancers · doi:10.3390/cancers13225735 · Cited by 187 · see citing works

Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review

Janež, A., Guja, C., Mitrakou, A., Lalic, N., Tankova, T., Czupryniak, L., Tabák, A. G., Prazny, M., Martinka, E., & Smircic-Duvnjak, L. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00743-7 · Cited by 177 · see citing works

Benefits and harms of intensive glycemic control in patients with type 2 diabetes

Rodriguez-Gutierrez, R., Gonzalez-Gonzalez, J. G., Zuñiga-Hernandez, J. A., & McCoy, R. G. (2019) · BMJ · doi:10.1136/bmj.l5887 · Cited by 152 · see citing works

Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective

De Block, C., Bailey, C., Wysham, C., Hemmingway, A., Allen, S. E., & Peleshok, J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14831 · Cited by 121 · see citing works

GLP-1a: Going beyond Traditional Use

Laurindo, L. F., Barbalho, S. M., Guiguer, E. L., da Silva Soares de Souza, M., de Souza, G. A., Fidalgo, T. M., Araújo, A. C., de Souza Gonzaga, H. F., de Bortoli Teixeira, D., de Oliveira Silva Ullmann, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020739 · Cited by 102 · see citing works

Alpha cell dysfunction in type 1 diabetes

Yosten, G. L. C. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.001 · Cited by 62 · see citing works

Protective Effects and Molecular Signaling of n-3 Fatty Acids on Oxidative Stress and Inflammation in Retinal Diseases

Suzumura, A., Terao, R., & Kaneko, H. (2020) · Antioxidants · doi:10.3390/antiox9100920 · Cited by 44 · see citing works

Incidence and predictors of type 1 diabetes among younger adults aged 20-45 years: the diabetes in young adults (DiYA) study

Lawrence, J. M., Slezak, J. M., Quesenberry, C., Li, X., Yu, L., Rewers, M., Alexander, J. G., Takhar, H. S., Sridhar, S., Albright, A., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108624 · Cited by 34 · see citing works

Association between self-care agency and depression and anxiety in patients with diabetic retinopathy

Zhang, B., Wang, Q., Zhang, X., Jiang, L., Li, L., & Liu, B. (2021) · BMC Ophthalmology · doi:10.1186/s12886-021-01883-w · Cited by 30 · see citing works

HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups

Sidorenkov, G., van Boven, J. F. M., Hoekstra, T., Nijpels, G., Hoogenberg, K., & Denig, P. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13332 · Cited by 24 · see citing works

Natural History of Chiari Malformations

Maher, C. O. (2020) · Springer eBooks · doi:10.1007/978-3-030-44862-2_22 · Cited by 1 · see citing works

Unnatural natural history of Duchenne muscular dystrophy

Dubowitz, V. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.11.005 · Cited by 4 · see citing works

DEPARTMENT OF LIBRARY SERVICES, BRITISH MUSEUM (NATURAL HISTORY), 1986. Annual bibliography of the history of natural history, Volume 2—publications of 1983. British Museum (Natural History). Pp iv + 106.

Mabberley, D. J. (1988) · Archives of Natural History · doi:10.3366/anh.1988.15.1.119

Natural History of Untreated Benign Prostatic Hyperplasia

Barry, M. J. (1995) · Springer eBooks · doi:10.1007/978-3-642-78826-0_12 · Cited by 2 · see citing works

THACKRAY, J. C. A guide to the official archives of The Natural History Museum, London. Society for the History of Natural History on behalf of The Natural History Museum, London: 1998. Pp xix, 174. Price £25.00 (US$42); price to SHNH members £18.75 (US$32). ISBN 0-901-843-08-3

Davis, P. S. (2000) · Archives of Natural History · doi:10.3366/anh.2000.27.1.152